PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33040801-3	2020	Piceatannol has been shown to effectively modulate JAK/STAT, Wnt/beta-catenin, mTOR pathway in different cancers.	3,3',4,5'-tetrahydroxystilbene	0-11	catenin beta 1	Homo sapiens	65-77	
29231998-5	2018	Furthermore, we show that the inhibitor of Spleen Tyrosine Kinase (Syk) piceatannol decreases centrosomal PTyr142 beta-catenin levels, indicating that Syk regulates centrosome PTyr142 beta-catenin.	3,3',4,5'-tetrahydroxystilbene	72-83	catenin beta 1	Homo sapiens	114-126	
29231998-5	2018	Furthermore, we show that the inhibitor of Spleen Tyrosine Kinase (Syk) piceatannol decreases centrosomal PTyr142 beta-catenin levels, indicating that Syk regulates centrosome PTyr142 beta-catenin.	3,3',4,5'-tetrahydroxystilbene	72-83	catenin beta 1	Homo sapiens	184-196	
22245592-6	2012	We also found that myricetin, quercetin, piceatannol and resveratrol up-regulated HIF-1alpha and down-regulated c-Myc, PHD2 and beta-catenin expressions via SIRT1 activation, in a manner that mimics hypoxic preconditioning.	3,3',4,5'-tetrahydroxystilbene	41-52	catenin beta 1	Homo sapiens	128-140	
24470348-0	2014	Piceatannol exhibits selective toxicity to multiple myeloma cells and influences the Wnt/ beta-catenin pathway.	3,3',4,5'-tetrahydroxystilbene	0-11	catenin beta 1	Homo sapiens	90-102	
24470348-4	2014	In this study, we identified piceatannol as an inhibitor of the Wnt/beta-catenin pathway and as a potent inducer of apoptosis in myeloma cells.	3,3',4,5'-tetrahydroxystilbene	29-40	catenin beta 1	Homo sapiens	68-80